| POLYPEPTIDE GROUP SF -,01 |
| Schweiz |
| Gesundheit |
| CH1110760852 / A3CNHV |
| 8H0 (Frankfurt) |
| FRA:8H0, ETR:8H0, 8H0:GR |
| - |
| https://www.polypeptide.c.. |
|
PolyPeptide Group AG is a specialized Contract Development & Manufacturing Organization (CDMO) focused on peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). Established with roots dating back to 1952 in Malmö, Sweden, it su..
>Volltext.. |
| 1056.19 Mio. EUR |
| 1111.48 Mio. EUR |
| 393.88 Mio. EUR |
| 44.5 Mio. EUR |
| -21.59 Mio. EUR |
| -0.65 EUR |
| 131.23 Mio. EUR |
| 74.97 Mio. EUR |
| 78.1 Mio. EUR |
| 0.4 |
| 14.96% |
| -8.09% |
| - |
| - |
| - |
| - |
| POLYPEPTIDE |
| 08.04.26 |
|